Atlas Trials

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

Clinical trial NCT00169143 · COMPLETED

Trial details

NCT number
NCT00169143
Sponsor
Lymphoma Study Association
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Untreated CD20-positive Large B-cell Lymphoma
Start date
2004-05-01
Primary completion
2007-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.